News & Events

Pioneering Progress in Immunotherapy: Recap of the ImmunoSep Symposium

We are pleased to share with you the recap of the recent "International Symposium on Immunotherapy of Severe Infections", in which course the ImmunoSep partners gathered in the beautiful Kalamata, G...

Register now for the International Symposium on Immunotherapy of Severe Infections!

Join a broad diversity of scientists in the field of Immunotherapy as they convene for the International Symposium on Immunotherapy of Severe Infections, from 16 to 17 May in Kalamata, Greece. Aimed...

Interview with Evangelos Giamarellos, Coordinator of the ImmunoSep Clinical Trial, highlighting trial achievements

It is with particular pride and pleasure that the Hellenic Institute for the Study of Sepsis (HISS) announced the enrolment of the last patient for the ImmunoSep clinical trial this week. The st...

Save the date: International Symposium on Immunotherapy of Severe Infections

The ImmunoSep Consortium is pleased to announce the International Symposium titled “Immunotherapy of Severe Infections” taking place from the 16th to 17th of May 2024 in Kalamata, Greece.

The p...

Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia

A researcher group led by Evangelos Giamarellos-Bourboulis recently published the results of a randomized controlled trial in The Lancet Respiratory Medicine.

In the study, 267 patients with commu...

Just published in the Horizon magazine: ImmunoSep article on new ways to tackle bloodstream infections

The article titled ‘Europe steps up fight against deadly sepsis and antibiotic-resistant bacteria’, which has just been published in HORIZON: The EU Research & Innovation magazine, explains how EU res...

Milestone reached – the ImmunoSep study has now recruited the 200th patient

The key to success in the ImmunoSep project is its clinical study and thus the recruitment of patients. The study is set up as a randomised controlled trial of immunotherapy in five European countries...

ImmunoSep prepares for its final stretch in Jena

The ImmunoSep partners met on 08 and 09 June for its 3rd Progress meeting, kindly hosted by the Jena University Hospital. The meeting venue at the 29th floor of the Scala tower provided a breathtaking...

Meet the ImmunoSep Partners at the 4th World Sepsis Congress

On 25th and 26th of April 2023, the World Sepsis Congress will take place and among the more than 80 speakers, five members of the ImmunoSep consortium will give exciting talks on different aspects of...

European Sepsis Alliance urges European governments and institutions to act

At the 6th ESA Annual Meeting that took place in Brussels on 21st of March, ESA Chair Evangelos Giamarellos called on national and European institutions and authorities to help improve sepsis care in...

ImmunoSep releases brandnew animated video on personalised immunotherapy in sepsis

ImmunoSep challenges the standard ‘one-size-fits-all’ treatment approach to sepsis, which currently consists of the prescription of antibiotics and the introduction of intensive care units, by develop...

Immune classification in sepsis

Results of the PROVIDE study, sponsored by ImmunoSep partner and clinical trial coordinator, Hellenic Institute for the Study of Sepsis, on 240 patients with septic shock achieved the immune classif...

Catching up and planning ahead: ImmunoSep progress meeting finally in person again

For its 2nd progress meeting the ImmunoSep consortium has finally been able to come together again in person. After more than two years of virtual gatherings, partners met in Athens, Greece, on the 2n...

2021 web conference of the European Shock Society

The European Shock Society meets the ImmunoSep consortium for personalized sepsis treatment- join this and many other attractive research sessions for free durig the 19th CONFERENCE OF THE EUROPEAN...

Picking up wind - EU Research Project ImmunoSep kicks off

Defying the gale-force winds and heavy rain of storm ‘Sabine’, the multinational ImmunoSep consortium came together in Nijmegen, The Netherlands, to successfully kick-off the new research project Immu...

Launch of EU Research Project ImmunoSep: Advancing Personalised Immunotherapy in Sepsis